|Bid||98.00 x 800|
|Ask||123.00 x 900|
|Day's Range||109.41 - 114.51|
|52 Week Range||97.10 - 123.50|
|Beta (3Y Monthly)||0.49|
|PE Ratio (TTM)||24.40|
|Earnings Date||Apr 23, 2018 - Apr 27, 2018|
|Forward Dividend & Yield||4.00 (3.50%)|
|1y Target Est||106.88|
Strong results from Procter & Gamble are sparking hopes that tough times are ending for makers of household consumer goods. P&G said Wednesday that organic sales were up 4% for the second straight quarter. Sales were just flat when weakening foreign currencies were included, but the underlying growth is still an encouraging sign.Organic sales growth, which strips out both currency impact and acquisitions, had previously languished in the 1% to 2% range for many quarters.
posted weaker-than-expected fourth-quarter earnings Wednesday as profit margins declined in a "challenging" environment of higher input prices and increased currency market volatility. Kimberly-Clark said adjusted earnings for the three months ending in December came in at $1.60 per share, 5 cents shy of the consensus forecast of $1.60 but up 1.9% from the same period last year.
Procter & Gamble earnings were better-than-expected for fiscal Q2. The Dow Jones stock rose before the open.
Consumer staples giant Proctor & Gamble (NYSE:PG) reported second-quarter numbers before the bell on Wednesday that were largely better than expected. Revenues topped expectations by about 1.5%. Earnings came in roughly 3% above expectations. Organic sales growth was above consensus. The e-commerce business was red hot. Management said that they didn't see any slowdown China. The guide was hiked. Overall, it was a solid double-beat-and-raise quarter. PG stock rose over 4% in response. But PG stock was unable to claw its way back to the near $100 highs this stock was at in early December. Instead, the post-earnings rally maxed out short of all time highs. Why? Valuation. Despite the strong second-quarter numbers, valuation concerns remain for PG stock. The closer this stock gets to $100 without earnings and sales heading meaningfully higher, the bigger those valuation concerns get. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Considering this is a low-single-digit revenue growth and mid-single-digit earnings growth company, it will take at least several quarters for sales and profits to head meaningfully higher. As such, it will take at least several quarters until PG stock is fundamentally supported at $100, meaning near term upside is capped by what is already a full valuation. ### The Numbers Were Good for PG Stock Proctor & Gamble's second-quarter numbers were very good, and underscore that this company is not only surviving a global economic slowdown, but actually thriving where others are struggling. * 7 Stupidly Cheap Stocks to Buy Now Organic sales growth came in at 4%. That is much higher than the consensus expectation for 2.6% growth. It is also above the 1%-4% range which organic sales growth has hung out in for the past several years. More than that, consumer staples peer Kimberly-Clark (NYSE:KMB) reported just 3% organic sales growth in the same overlapping period. Also, whereas Apple (NASDAQ:AAPL) and other companies have reported material weakness in China, Proctor & Gamble said China was essentially business as usual during the quarter. Overall, the broad top-line takeaway is bullish. Many companies are seeing their growth rates fall, or are experiencing material weakness in emerging markets. Proctor & Gamble is suffering from neither. Instead, the sales growth trajectory is improving, and emerging markets aren't slowing. The story on margins wasn't as great. Gross and operating margins both came in below consensus. But, the miss on each line was 40 basis points or less. Plus, that miss was more than made up for by a hiked full year guide. In the big picture, Proctor & Gamble had a really good quarter. But, the stock was already priced for a really good quarter, and that's why upside from here still looks limited. ### Procter & Gamble's Valuation Is Still A Concern A double-beat-and-raise quarter doesn't dismantle the bear thesis on PG stock, which is predicated on an overextended valuation. From fiscal 2014 through fiscal 2018, Proctor & Gamble's organic sales growth ranged from 1% to 3%, while core EPS growth ranged from -2% to 8%. On average, Proctor & Gamble was a low-single-digit organic sales grower and low-to-mid-single-digit core EPS grower. That growth profile coupled with a 20 forward multiple (the stock's average valuation over the past five years) produced sub-par returns for PG stock. Over the past five years, PG stock has risen less than 20%, while the S&P 500 is up more than 40% during that stretch. Clearly, a 20 forward multiple on a low single revenue growth and low to mid single digit earnings growth profile didn't cut it for PG stock over the past five years. Considering rates are only going up and the global economy is only slowing, such a combination won't cut it for PG stock over the next five years, either. Unfortunately, PG stock today is defined by a very similar dynamic. Organic sales growth this year is expected at 3%. Core EPS growth is expected at 5.5%, and that's a three year low. Thus, over the next five years, a reasonable estimate for PG's growth profile is low-single-digit revenue growth and low-to-mid-single-digit EPS growth, the same as it has been over the past five years. Meanwhile, the forward P/E multiple today is just a hair below 20, nearly identical to where it's hovered over the past five years. Thus, PG stock today is very similar to its "average self" over the past five years. That "average self" resulted in 20 points of under-performance relative to the S&P 500. As such, there really isn't much reason to get excited about PG stock here. ### Bottom Line on PG Stock Proctor & Gamble is a great company with solid and defensive fundamentals. The company isn't going anywhere anytime soon, and steady earnings growth is almost a guarantee. But, today's valuation already accounts for all those positives. Upside in PG stock from here in any time frame looks limited. As such, the post-earnings rally isn't anything to get too excited about. As of this writing, Luke Lango was long AAPL. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Consumer Stocks to Buy for Income * 7 Dark Horse Stocks You Really Need to Look at for 2019 * 7 Retail Stocks to Buy for the Rise of Menswear Compare Brokers The post Valuation Concerns Remain for Proctor & Gamble Stock Despite Strong Q2 appeared first on InvestorPlace.
Procter & Gamble shares moved higher after the company reported stronger-than-expected earnings, but traders will be keeping an eye on these levels.
U.S. equities are rebounding from Tuesday's ugliness with aplomb as Wall Street continues to feel the warm, positive vibes from newly dovish Federal Reserve chairman Jay Powell. Moreover, senior White House officials continue to soften their shutdown stance, with reports that green cards are on the table for DACA recipients, setting the stage for a breakthrough in the stalemate that could get hundreds of thousands of federal workers back on the job. * 10 Hot Stocks to Buy Right Now As a result, a number of large-cap stocks are pushing strongly higher as the major indices hold above critical resistance levels. The Dow Jones Industrial Average has spent three days above its 50-day moving average and looks ready to close in on its 200-day average next. InvestorPlace - Stock Market News, Stock Advice & Trading Tips In anticipation, here are five large-cap stocks to watch: ### Comcast (CMCSA) Comcast (NASDAQ:CMCSA) shares have punched up and over their 50-day moving average to return to the highs last seen in early December. This after a bounce on the 20-day average on Tuesday. Watch for a run at the prior high of $39.50, which would be worth a gain of roughly 7% from here. The company reported results before the bell this morning. Earnings of 64 cents per share beat estimates by a penny on a 26.1% rise in revenues thanks to a 5.2% increase in Cable Communications sales. Previously, the company reported on Oct. 25 with earnings of 65 cents per share beating estimates by 4 cents on a 5% rise in revenues. ### Procter & Gamble (PG) Shares of Procter & Gamble (NYSE:PG) are pushing to fresh highs, testing above the $96-a-share level, after reporting better-than-expected quarterly results and raising forward guidance. Earnings of $1.25 per share were a 5% increase from the prior year driven by a lower tax rate. Organic sales growth clocked in at 4%, which is healthy in this environment. * 10 Consumer Stocks to Buy for Income Looking ahead, management raised the upper end of their organic sales growth guidance by 1% to a range of 2% to 4% for fiscal 2019. The company seems to be avoiding issues such as price pressure and higher transport costs hitting competitors like Kimberly-Clark (NYSE:KMB). ### United Technologies (UTX) United Technologies (NYSE:UTX) shares are on the move in a big way, testing above their 50-day moving average and marking a near-20% rise off of the late December low. Watch for prices to chase down the 200-day average, which would be worth another 10% move from here. The company reported results this morning before the bell. Earnings of $1.95 per share beat estimates by 42 cents on a 15.1% rise in revenues. Forward guidance was raised above estimates as well. Previously, the company reported on Oct. 23 with earnings of $1.93 per share beating estimates by 42 cents on a 15.1% rise in revenues. ### Starbucks (SBUX) Starbucks (NASDAQ:SBUX) shares have been a rare bright spot for the market, rising steadily since the summer, they have shrugged off the nastiness seen elsewhere. SBUX stock is back over its 50-day moving average and is closing in on its prior high set in November. This comes despite a downgrade by Goldman Sachs earlier this month. * 7 Stocks to Buy That Lost 20% Over Past 90 Days The company will next report results on Jan. 24 before the bell. Analysts are looking for earnings of 66 cents per share on revenues of $6.5 billion. When the company last reported on Nov. 1, earnings of 62 cents per share beat estimates by 2 cents on a 10.6% rise in revenues. ### Coca-Cola (KO) Coca-Cola (NYSE:KO) shares are rising out of a two-month consolation base, setting the stage for a run at the 50-day moving average. A return to the prior highs would be worth a 4% gain from here. Analysts at UBS resumed coverage on the stock back in December with a Buy rating. CEO James Quincey was also on CNBC last month discussing the potential for a cannabis infused drink. The company will next report results on Feb. 14 before the bell. Analysts are looking for earnings of 43 cents per share on revenues of $7.1 billion. When the company last reported on Oct. 30, earnings of 58 cents per share beat estimates by 3 cents despite a 9.2% drop in revenues. As of this writing, William Roth did not hold a position in any of the aforementioned securities. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Consumer Stocks to Buy for Income * 7 Dark Horse Stocks You Really Need to Look at for 2019 * 7 Retail Stocks to Buy for the Rise of Menswear Compare Brokers The post 5 Large-Cap Stocks Blitzing Higher appeared first on InvestorPlace.
Kimberly-Clark (KMB) reports mixed Q4 results. Top line beats the Zacks Consensus Estimate, while the bottom line misses the same.
With 76 of the S&P 500 reported already, fourth-quarter numbers are strong. First-quarter estimated numbers are still coming down, but the fears of an earnings recession — when you get consecutive quarters of negative earnings growth — are not materializing. The big stocks reporting on Wednesday have all provided reassuring guidance for 2019, including Dow components United Technologies UTX and IBM IBM , both above consensus guidance, and Procter & Gamble PG , which was in line with guidance on strong sales.
Procter & Gamble Beats Fiscal 2019 Q2 Estimates, Ups GuidanceKey takeaways Maintaining strong organic sales, Procter & Gamble (PG) reported stronger-than-expected fiscal 2019 second-quarter (ended December 31) results today. Its stock was
Margin Headwinds Hurt Kimberly-Clark’s Fourth-Quarter EPSKey takeaways After reporting lower-than-expected fourth-quarter earnings, Kimberly-Clark (KMB) was trading ~3% lower before the market opened today. Meanwhile, rival Procter & Gamble
Key InsightsNew Chief Executive Officer Michael Hsu, who took the reins from long-time CEO Tom Falk at the start of this year, is up against shrinking margins, higher commodity costs and currency volatility. Earlier Wednesday, Procter & Gamble Co. had raised the upper end of its own forecast for the year, but like Kimberly cited a “challenging” environment. To boost growth and reduce expenses, Kimberly introduced a plan dubbed “K-C Strategy 2022,” which refers to the year the company will turn 150 years old.
Kimberly-Clark (KMB) delivered earnings and revenue surprises of -4.76% and 2.44%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
(Reuters) - Kimberly-Clark Corp on Wednesday reported quarterly profit that missed Wall Street estimates, as the Kleenex-tissues maker continued to struggle with rising raw materials costs and a strong ...
Kimberly-Clark Corp on Wednesday reported quarterly profit that missed Wall Street estimates, as the Kleenex-tissues maker continued to struggle with rising raw materials costs and a strong U.S. dollar, ...
On a per-share basis, the Dallas-based company said it had net income of $1.18. Earnings, adjusted for restructuring costs and pretax expenses, came to $1.60 per share. The results did not meet Wall Street ...
Kimberly-Clark Corp. shares fell 2.2% in Wednesday premarket trading after the consumer goods company reported earnings that missed estimates. Net income totaled $411 million, or $1.18 per share, down from $617 million, or $1.75 per share, for the same period last year. Adjusted EPS was $1.60, missing the $1.65 FactSet consensus. Sales totaled $4.57 billion, down 1% from $4.60 billion last year but ahead of the $4.45 billion FactSet consensus. Sales in the personal care segment fell while the K-C Professional segment sales rose. Kimberly-Clark expects 2019 sales to fall 1% to 2% from $18.49 billion in 2018. Adjusted EPS is expected to be $6.50 to $7.50. The FactSet consensus is for sales of $18.36 billion and EPS of $6.66. Kimberly-Clark shares have lost 2.2% in the past year while the S&P 500 index is down 7.3% for the period.
Kleenex-tissues maker Kimberly-Clark Corp on Wednesday reported better-than-expected quarterly sales, as it raised prices across the board to offset higher raw material and transportation costs. Net sales ...
Will Colgate-Palmolive’s Q4 Results Stall the Recovery in Its Stock?(Continued from Prior Part)Goldman upgraded CL stock Most of the analysts covering Colgate-Palmolive (CL) have maintained neutral stances on its stock. However, Goldman Sachs
DALLAS , Jan. 23, 2019 /PRNewswire/ -- Kimberly-Clark Corporation (NYSE: KMB) today reported year-end 2018 results, provided its 2019 outlook and introduced its K-C Strategy 2022 strategic plan. Executive ...